Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Viruses|December 23, 2023
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm VirusesHarry Stannard, Paulina Koszalka, Nikita Deshpande, et al.
The Journal of General Virology|January 4, 2018
Predominant role of IPS-1 over TRIF adaptor proteins in early innate immune response against Zika virus in miceJocelyne Piret, Julie Carbonneau, Chantal Rhéaume, et al.
The Journal of General Virology|June 21, 2017
In vitro and in vivo evidence of a potential A(H1N1)pdm09 antigenic drift mediated by escape mutations in the haemagglutinin Sa antigenic siteMiguel Retamal, Yacine Abed, Chantal Rhéaume, et al.
Viruses|November 27, 2025
Comparative Analysis of Extracellular Vesicle and Virus Co-Purified Fractions Produced by Contemporary Influenza A and B Viruses in Different Human Cell LinesAude Wantchecon, Julien Boucher, Henintsoa Rabezanahary, et al.
Antiviral Research|April 21, 2018
Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 virusesVéronique Tu, Yacine Abed, Clément Fage, et al.
Viruses|November 8, 2018
Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza VirusMariana Baz, Julie Carbonneau, Chantal Rhéaume, et al.
The Journal of Infectious Diseases|January 27, 2010
Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) virusesMariana Baz, Yacine Abed, Philippe Simon, et al.
Virus Research|June 4, 2013
H5N1 vaccines in humansMariana Baz, Catherine J Luke, Xing Cheng, et al.
Virus Research|September 22, 2006
Influenza B viruses isolated in Uruguay during the 2002-2005 seasons: genetic relations and vaccine strain matchNatalia Goñi, Mariana Baz, Dora Ruchansky, et al.
Antiviral Therapy|July 12, 2017
In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirinMariana Baz, Nathalie Goyette, Bryan D Griffin, et al.
Pageof 7